Participant flow16

How many started, completed or left each group, period by period.

1 to 16 of 16

Period	Milestone	Group	Participants
Overall Study	STARTED	Abemaciclib 150 mg	12
Overall Study	STARTED	Abemaciclib 200 mg	14
Overall Study	Received at Least One Dose of Study Drug	Abemaciclib 150 mg	12
Overall Study	Received at Least One Dose of Study Drug	Abemaciclib 200 mg	13
Overall Study	PK 100 mg Abemaciclib Dose	Abemaciclib 150 mg	5
Overall Study	PK 100 mg Abemaciclib Dose	Abemaciclib 200 mg	0
Overall Study	PK 150 mg Abemaciclib Dose	Abemaciclib 150 mg	0
Overall Study	PK 150 mg Abemaciclib Dose	Abemaciclib 200 mg	2
Overall Study	Death On Treatment	Abemaciclib 150 mg	1
Overall Study	Death On Treatment	Abemaciclib 200 mg	0
Overall Study	Progressive Disease	Abemaciclib 150 mg	7
Overall Study	Progressive Disease	Abemaciclib 200 mg	9
Overall Study	COMPLETED	Abemaciclib 150 mg	8
Overall Study	COMPLETED	Abemaciclib 200 mg	9
Overall Study	NOT COMPLETED	Abemaciclib 150 mg	4
Overall Study	NOT COMPLETED	Abemaciclib 200 mg	5

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02919696/flow